These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7927476)

  • 1. [Helicobacter pylori and molecular biology--virulence, diagnosis and vaccine development].
    Suerbaum S
    Immun Infekt; 1994 Aug; 22(4):137-41. PubMed ID: 7927476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
    Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.
    Corthésy B; Boris S; Isler P; Grangette C; Mercenier A
    J Infect Dis; 2005 Oct; 192(8):1441-9. PubMed ID: 16170763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.
    Guo L; Liu K; Zhao W; Li X; Li T; Tang F; Zhang R; Wu W; Xi T
    Appl Microbiol Biotechnol; 2013 Mar; 97(6):2367-78. PubMed ID: 23064457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The design of vaccines against Helicobacter pylori and their development.
    Del Giudice G; Covacci A; Telford JL; Montecucco C; Rappuoli R
    Annu Rev Immunol; 2001; 19():523-63. PubMed ID: 11244046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of Helicobacter pylori and perspectives of vaccine development against an emerging pathogen.
    Rappuoli R; Covacci A; Ghiara P; Telford J
    Behring Inst Mitt; 1994 Dec; (95):42-8. PubMed ID: 7755508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral immunogenicity and protective efficacy in mice of a carrot-derived vaccine candidate expressing UreB subunit against Helicobacter pylori.
    Zhang H; Liu M; Li Y; Zhao Y; He H; Yang G; Zheng C
    Protein Expr Purif; 2010 Feb; 69(2):127-31. PubMed ID: 19651219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
    Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL
    Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunization against Helicobacter pylori--a future concept.
    Michetti P
    J Gastroenterol; 1998; 33 Suppl 10():66-8. PubMed ID: 9840022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant antigen from Helicobacter pylori urease as vaccine against H. pylori-associated disease.
    Fujii R; Morihara F; Fukushima K; Oku T; Hifumi E; Uda T
    Biotechnol Bioeng; 2004 Jun; 86(7):737-46. PubMed ID: 15162449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
    Guo L; Liu K; Xu G; Li X; Tu J; Tang F; Xing Y; Xi T
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards the development of vaccines against Helicobacter pylori: status and issues.
    Del Giudice G
    Curr Opin Investig Drugs; 2001 Jan; 2(1):40-4. PubMed ID: 11527009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of vaccines against Helicobacter pylori.
    Del Giudice G; Malfertheiner P; Rappuoli R
    Expert Rev Vaccines; 2009 Aug; 8(8):1037-49. PubMed ID: 19627186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
    Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
    Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori infection and gastroduodenal disease: a comparison of endoscopic findings, histology, and urease test data.
    Haruma K; Okamoto S; Sumii K; Yoshihara M; Tari A; Teshima H; Shimamoto T; Takehara Y; Tanaka S; Yamamoto G
    Hiroshima J Med Sci; 1992 Sep; 41(3):65-70. PubMed ID: 1293070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric flagellin as the self-adjuvanting antigen for the activation of immune response against Helicobacter pylori.
    Mori J; Vranac T; Smrekar B; Cernilec M; Serbec VČ; Horvat S; Ihan A; Benčina M; Jerala R
    Vaccine; 2012 Aug; 30(40):5856-63. PubMed ID: 22819990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving Helicobacter pylori vaccine development forward with bioinformatics and immunomics.
    Moise L; Moss SF; De Groot AS
    Expert Rev Vaccines; 2012 Sep; 11(9):1031-3. PubMed ID: 23151160
    [No Abstract]   [Full Text] [Related]  

  • 18. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
    Zavala-Spinetti L; Breslin MB; Correa H; Bégué RE
    Helicobacter; 2006 Dec; 11(6):517-22. PubMed ID: 17083372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against Helicobacter pylori.
    Lee A
    J Gastroenterol; 1996 Nov; 31 Suppl 9():69-74. PubMed ID: 8959525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation, immunity and vaccines for Helicobacter pylori.
    Del Giudice G; Michetti P
    Helicobacter; 2004; 9 Suppl 1():23-8. PubMed ID: 15347302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.